Closed Solicitation · DEPARTMENT OF HEALTH AND HUMAN SERVICES

    NOTICE OF INTENT TO AWARD A BLANKET PURCHASE AGREEMENT TO A SINGLE FIRM FOR STERILELY COMPOUNDED PHARMACEUTICALS VIA 503B COMPOUNDING PHARMACIES FOR GALLUP INDIAN MEDICAL CENTER

    Sol. IRC-GSUT2-20260002Special NoticeWINDOW ROCK, AZ
    Closed
    STATUS
    Closed
    closed Jan 28, 2026
    POSTED
    Jan 13, 2026
    Publication date
    NAICS CODE
    325412
    Primary industry classification
    PSC CODE
    6505
    Product & service classification

    AI Summary

    The Gallup Indian Medical Center intends to award a Blanket Purchase Agreement for sterilely compounded pharmaceuticals from an FDA-designated 503B facility. The selected vendor, Fagron Compounding Services LLC, will provide various medications on an as-needed basis. Interested vendors may submit capability statements by January 28, 2026. This opportunity falls under Simplified Acquisition Procedures.

    Contract details

    Solicitation No.
    IRC-GSUT2-20260002
    Notice Type
    Special Notice
    Posted Date
    January 13, 2026
    Response Deadline
    January 28, 2026
    NAICS Code
    325412AI guide
    PSC / Class Code
    6505
    Primary Contact
    Rodney Brown
    State
    AZ
    ZIP Code
    86515
    AI Product/Service
    product

    Description

    The Navajo Area Indian Health Service, Gallup Service Unit in Gallup, NM, intends to award a single Blanket Purchase Agreement (BPA) with Fagron Compounding Services LLC (UEI: F7QNV46N18Q4) doing business as Fagron Sterile Services for sterilely compounded pharmaceuticals from an FDA-designated 503B facility on an as-needed basis. Items include Phenylephrine 100mcg.ml, Succinylcholine 20mg/10ml, LET 5ml syringe, Oxytoxin 30 units in 500ml (sterile to sterile and API), Epinephrine 8mg per 250ml bag (or other strength/volumes of the same medications in IV bags as available and required on an as-needed basis). Products must be sterilely compounded in an FDA approved facility with a beyond use date of at least 30 days from manufacture.

    The anticipated period of performance is:

    Base Period: 2/1/2026-1/31/2027

    Option Period One: 2/1/2027-1/31/2028

    Option Period Two: 2/1/2028-1/31/2029

    Option Period Three: 2/1/2029-1/31/2030

    Option Period Four: 2/1/2030-1/31/2031

    The applicable North American Industry Classification System (NAICS) code assigned to this procurement is 325412- Pharmaceutical Preparation Manufacturing with a small business size standard of 1,300 employees.

    No further awards will be made unless the need for Gallup Indian Medical Center changes. The prospective BPA identified in this notice is sufficient at this time. The identified vendor has the capability to provide sterilely compounded pharmaceuticals in a 503B facility and market research indicates the vendor is the only source. In accordance with Part 12.201-1(e)(3)(i)(B), BPAs may be established with a single firm from which numerous individual purchases at or below the simplified acquisition threshold will likely be made in a given period.

    Any other sources that believe they are capable of fulfilling the government requirements as described are encouraged to submit their capability statement, price lists, and catalogs to the point of contact below via email only and no later than 1/28/2026 at 10:00AM (MST). In the event additional BPAs are deemed to be in the best interest of the government, capable vendors may be contacted and be requested to establish a BPA with the Government.

    This notice of intent is not a request for quotations and a solicitation will not be issued.

    Primary Point of Contact:

    Rodney Brown, Contract Specialist

    Email: Rodney.Brown@ihs.gov

    Key dates

    1. January 13, 2026Posted Date
    2. January 28, 2026Proposals / Responses Due

    AI search tags

    Frequently asked questions

    NOTICE OF INTENT TO AWARD A BLANKET PURCHASE AGREEMENT TO A SINGLE FIRM FOR STERILELY COMPOUNDED PHARMACEUTICALS VIA 503B COMPOUNDING PHARMACIES FOR GALLUP INDIAN MEDICAL CENTER is a federal acquisition solicitation issued by DEPARTMENT OF HEALTH AND HUMAN SERVICES. Review the full description, attachments, and submission requirements on SamSearch before the response deadline.

    SamSearch Platform

    Stop searching. Start winning.

    AI-powered intelligence for the right opportunities, the right leads, and the right time.